|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
Department of Physiology and Institute of Cardiovascular Sciences and Medicine, The University of Hong Kong, Hong Kong, China
Submitted 30 March 2005 ; accepted in final form 27 September 2005
| ABSTRACT |
|---|
|
|
|---|
-opioid receptor agonist, U50488H (UP), followed by blockade of HSP70 with a selective antisense oligonucleotide and subsequently subjected to simulated ischemia. We determined the following: 1) the Ca2+ transients induced by electrical stimulation and caffeine, which provide the overall picture of Ca2+ homeostasis; 2) expression of RyR, SERCA, and NCX; and 3) Ca2+ fluxes via NCX by the use of 45Ca2+ in the rat ventricular myocyte. We found that UP increased the activity of RyR, SERCA, and NCX and the expression of RyR and SERCA. These effects led to increases in the release of Ca2+ from the sarcoplasmic reticulum via RyR and in the removal of Ca2+ from the cytoplasm by reuptake of Ca2+ to the SR via SERCA and by extrusion of Ca2+ out of the cell via NCX. UP also reduced mitochondrial Ca2+ accumulation. All of the effects of UP were either abolished or significantly attenuated by blockade of HSP70 synthesis with a selective antisense oligonucleotide. The results are evidence that activation of HSP70 by preconditioning improves the ischemia-impaired Ca2+ homeostasis at multiple sites in the heart, which may be responsible, at least partly, for attenuated Ca2+ overload, improved recovery in contractile function, and cardioprotection.
intracellular Ca2+,
-opioid receptor; Na+/Ca2+ exchanger; ryanodine receptor; sarco(endo)plasmic reticulum Ca2+-ATPase
-opioid receptor (
-OR) stimulation with the
-OR agonist, U50488H (UP) (13, 29). More important, this cardioprotection is accompanied by attenuation of the intracellular Ca2+ concentration ([Ca2+]i) overload (13), which is believed to be a precipitating cause of myocardial injury upon ischemia and reperfusion. The mechanisms responsible for Ca2+ handling leading to alterations in [Ca2+]i are not known. It is well known that Ca2+ homeostasis within the myocyte is exquisitely controlled by regulatory proteins in sarcolemmal and sarcoplasmic reticulum (SR) membranes. Ca2+ enters the cell via the L-type Ca2+ channel when the sarcolemmal membrane is depolarized. Entry of Ca2+ triggers further release of Ca2+ via the ryanodine receptor (RyR) of the SR, leading to a sudden increase in [Ca2+]i, known as a [Ca2+]i transient (8). The elevated [Ca2+]i, which leads to contraction, is removed mainly to the SR by the Ca2+-ATPase (SERCA) and out of the cell by the Na+/Ca2+ exchanger (NCX). Some Ca2+ released from the SR is transferred to mitochondria, another reservoir of Ca2+, via a coupling of RyR and closely apposed mitochondrial membrane (9). Thus both [Ca2+]i and mitochondrial Ca2+ ([Ca2+]m) change in parallel in response to alterations in Ca2+ handling by the SR and pathological situations. It has been shown that upon myocardial ischemia and reperfusion, overload of both [Ca2+]i and [Ca2+]m occur and attenuation of [Ca2+]m, but not [Ca2+]i, overload is responsible for improved recovery in contractile functions (14).
We therefore hypothesized that activation of HSP70 by preconditioning, which confers delayed cardioprotection, may restore [Ca2+]i homeostasis by restoring the activities taking place in sarcolemmal and SR membranes. To test this hypothesis, we investigated the Ca2+ handling in isolated ventricular myocytes preconditioned with U50488H, followed by blockade of HSP70 synthesis with a selective antisense (AS) oligonucleotide and subsequently subjected to simulated ischemia. We focused on Ca2+ release from the SR and removal of Ca2+ from the cytoplasm back to the SR and out of the myocyte via the NCX. We used three approaches, namely, measurement of the Ca2+ transients induced by electrical stimulation or caffeine, which provide information on overall dynamic changes in Ca2+ homeostasis; expression of proteins that handle Ca2+ fluxes across sarcolemmal and SR membranes; and actual Ca2+ fluxes across the NCX. We also measured the changes in [Ca2+]m. Results showed that activation of HSP70 by preconditioning attenuated the impaired Ca2+ handling at multiple sites, namely, RyR, SERCA, and NCX, which may be responsible, at least partly, for restoring Ca2+ homeostasis to normal.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-OR agonist, 30 µM U50488H or normal Krebs solution (vehicle pretreatment; VP) for 30 min. After incubation in culture medium for 20 h, with or without the presence of AS or sense oligonucleotides (10 µM) of HSP70, myocytes were then subjected to severe metabolic inhibition and anoxia (MeI/A) for 10 min by incubation in glucose-free Krebs solution containing 10 mM 2-deoxy-D-glucose (2-DOG), an inhibitor of glycolysis, and 10 mM sodium dithionite (Na2S2O4), an oxygen scavenger (10). Finally, the myocytes were transferred back to normal Krebs solution for 10-min reperfusion. A 20-h incubation period was adopted based on our previous studies, in which it was shown that delayed cardioprotection was most marked at 20 h after preconditioning (27), when there was also increased expression of HSP70 (29).
|
Measurement of [Ca2+]i transients in the single myocyte. [Ca2+]i transients were measured using a spectrofluorometric method with fura-2 AM as the Ca2+ indicator. Ventricular myocytes were incubated with 5 µM fura-2 AM for 30 min. Fluorescent signals obtained at 340-nm and 380-nm excitation wavelengths were recorded and stored in the computer for data processing and analysis. To measure electrically induced [Ca2+]i transients (E[Ca2+]i), myocytes were electrically stimulated at 0.2 Hz, whereas the caffeine-induced [Ca2+]i transients (C[Ca2+]i) were recorded by applying 10 mM caffeine directly to the ventricular myocyte. The amplitude of E[Ca2+]i and C[Ca2+]i was determined as the difference between the resting and the peak [Ca2+]i levels; the time for 50% decay of the transients (t50) was used to quantitate the decay of both transients.
Plasma membrane purification and NCX assay. By following the procedures described previously (21) with some modifications, we sonicated cells using three 15-s bursts in ice-cold lysis buffer (0.6 M sucrose, 10 mM imidazole-HCl, pH 7.0). The homogenate was centrifuged at 1,000 g for 5 min. The first supernatant was centrifuged at 12,000 g for 30 min. The 12,000 g supernatant was diluted in the solution (pH 7.4) containing 160 mM NaCl, 20 mM HEPES-Tris, and 0.25 M sucrose and then centrifuged at 160,000 g for 70 min. The final pellet, representing the sarcolemma-enriched fraction, was dissolved in 0.5 ml of solution A (in mM: 100 NaCl, 50 LiCl, 6 KCl, and 20 HEPES-Tris, pH 7.4) and assayed for NCX activity. All solutions contained three protease inhibitors: 1 mg/ml aprotinin, 1 mM PMSF, and 1 mg/ml leupeptin.
Vesicle suspension (4 µl) was incubated for 50 min at 22°C to load Na+ via passive diffusion from the suspension medium, i.e., solution A. Afterward, 5 µl of the vesicle suspension was placed on the side of a polystyrene Eppendorf tube containing 95 µl of K+ reaction medium: 160 mM KCl, 0.1 mM CaCl2, 10 µCi 45CaCl2, 0.2 mM EGTA, 2 µM valinomycin, and 20 mM HEPES-Tris (pH 7.4). The free [Ca2+] in the medium was 50 µM as derived from calculation with the computer program Eq-Cal for Windows (Biosoft, 1996) for Ca2+-EGTA buffer. The Ca2+ influx was stopped by diluting the reaction mixture after 2, 5, or 10 s with 5 ml of ice-cold termination medium (160 mM KCl and 2 mM LaCl3). Na+-dependent specific Ca2+ uptake was defined as the total Ca2+ uptake minus unspecific Ca2+ uptake in solution B, which contained 0.2 mM EGTA, 0.1 mM CaCl2, 10 µCi 45CaCl2, and 2 µM valinomycin, i.e., a solution in which no Na+ gradient existed across the membrane. All samples were filtered under vacuum, and filters (GF/F; Whatman) were washed twice with 6 ml of 140 mM KCl and 0.1 mM LaCl3. The protein content of each sample was determined using a kit obtained from Bio-Rad and BSA as a standard.
PAGE and Western blot analysis. To detect the expression of RyR and SERCA, SR vesicles were obtained using a method adopted previously (21). Briefly, cells were sonicated on ice in an extraction medium containing (in mM) 15 Tris·HCl, 10 NaHCO3, 5 NaN3, 250 sucrose, and 1 EDTA (pH 7.0). The homogenate was centrifuged for 5 min at 3,000 g to remove cellular debris. The supernatant was further centrifuged at 48,000 g for 75 min. Then the pellet was suspended in a mixture of 0.6 mM KCl and 20 mM Tris·HCl (pH 7.0) and centrifuged at 48,000 g for 60 min. The final pellet was rehomogenized in 250 mM sucrose and 40 mM imidazole-HCl and stored at 70°C. All solutions contained three protease inhibitors: 1 mg/ml aprotinin, 1 mM PMSF, and 1 mg/ml leupeptin.
For the measurement of NCX, purification of plasma membrane vesicles was carried out as described above. The pellet representing the sarcolemma-enriched fraction was dissolved in the lysis buffer (0.6 M sucrose and 10 mM imidazole-HCl, pH 7.0) and stored at 70°C. The whole cell extracts were obtained for HSP70 and HSC70 detection as described previously (13).
Sample proteins (60 µg/lane) were separated in SDS-polyacrylamide gel (10%), and after being transferred, membranes were probed with mouse anti-RyR antibody (1:3,330), goat anti-SERCA2 antibody (1:400), mouse anti-NCX1 antibody (1:500), mouse anti-HSP70 antibody (1:2,000), or rat anti-HSC70 antibody (1:2,000). To ensure that equal amounts of protein were loaded on each lane, the membranes were stripped with stripping buffer and reblotted with a mouse anti-GAPDH antibody (1:6,000). Data are expressed as a ratio of the target protein to GAPDH.
Time-lapse recording of [Ca2+]m. To monitor [Ca2+]m, single myocytes loaded with rhod-2 fluorescent probe were scanned with a laser-scanning confocal microscope (Fluoview FV300; Olympus). After 20 h in culture, the cells were incubated with 10 µM rhod- 2 AM, which was reduced by sodium borohydride in advance for 2.5 h in 37°C incubator as described previously with some modifications (18). This method facilitates the selective accumulation of rhod-2 in the mitochondrial matrix.
The Ca2+-sensitive fluorescent indicator rhod-2 was excited at 543 nm, and the time-lapse confocal images (1,024 x 1,024 pixels) were sampled every 1 min. Experiments were analyzed with the use of Fluoview software (version 4.2; Olympus). [Ca2+]m was represented by the measured rhod-2 fluorescence intensity as a percentage of the intensity at the beginning of the experiment.
Blockade of synthesis of HSP70 with a selective AS oligonucleotides. The phosphorothioate AS (TGT TTT CTT GGC CAT) and sense oligonucleotides (ATG GCC AAG AAA ACA) to HSP70 were synthesized from sequences complementary to the initiation codon and four downstream codons of rat HSP70 mRNA (Life Tech). HSP70 synthesis has been demonstrated to be blocked after incubation with this AS at 10 µM in the studies of Kim et al. (11) and by our laboratory (13, 29). However, there were some limitations regarding this AS sequence, such as the relatively low melting temperature (36°C, Oligonucleotide Properties Calculator) and possible unspecific matches. To confirm that HSP70 was indeed targeted, we used another phosphorothioate AS oligonucleotide (5'-CAC CTT GCC GTG CTG GAA-3'; AS2) with much higher melting temperature (53°C), which may lower the likelihood of unspecific matches (4, 5). The S oligonucleotide (5'-TTC CAG CAC GGC AAG GTG-3'; S2) was used as the control. We obtained the same results as we did with AS of Kim et al. (11, 13, 29) in HSP70 expression and E[Ca2+]i responses (Figs. 1A and 2). Moreover, neither of the two AS oligonucleotides abolished the enhanced expression of HSC70 (the constitutive form of a 70-kDa stress protein), confirming their selectivity to HSP70 (Fig. 1B).
|
Statistical analysis. All data are expressed as means ± SE. One-way ANOVA, followed by Newman-Keuls multiple-comparison tests, were used to assess differences between the mean values within the same study. A difference of P < 0.05 was considered significant.
| RESULTS |
|---|
|
|
|---|
UP also enhanced the expression of HSC70, which is in agreement with our previous findings (29). Neither AS nor AS2 of HSP70 had any effect on HSC70 expression (Fig. 1B).
Effects of UP on amplitude, time to peak, and t50 of E[Ca2+]i in single ventricular myocyte subjected to MeI/A upon blockade of HSP70. The amplitude of E[Ca2+]i, representing the release of Ca2+ during excitation-contraction coupling and shown to be directly correlated with contraction (28), was markedly reduced after MeI/A and reperfusion. In agreement with our previous study, the reductions were restored by pretreatment with 30 µM U50488H, which was shown previously to confer delayed cardioprotection and enhance the expression of HSP70 (13, 29). Administration of either AS or AS2 to HSP70 during the incubation period abolished the effect of UP (Fig. 2A) as was also shown in the previous study (13).
Time to peak of E[Ca2+]i represents the rate of Ca2+ release from the SR, mainly via RyR. As shown in Fig. 2B, after 10 min of MeI/A, the time to peak of E[Ca2+]i was delayed by 35% compared with the time taken before treatment. UP significantly shortened the prolongation of the time to peak to 19%, indicating improved function of the RyR with preconditioning. However, the ameliorating effect of UP was completely abolished by either AS or AS2 to HSP70. On the other hand, coincubation with S or S2 oligonucleotides had a similar effect on UP. Similarly, after 10 min of reperfusion, the time to peak of E[Ca2+]i in UP was also significantly less than that in VP, and this effect was reversed by either AS or AS2 to HSP70.
The decay of E[Ca2+]i is mainly determined by Ca2+ uptake via SERCA, which is responsible for the removal of
90% Ca2+ from the cytoplasm (2). We therefore measured the value of t50 as an indicator of SERCA activity. As shown in Fig. 2C, after 10-min MeI/A and 10-min reperfusion, the t50 of E[Ca2+]i was increased to 137% and 123% of the control, respectively. However, UP restored the increased t50 to 109% and 104%, respectively. UP lost its attenuating effect in the presence of either AS or AS2 of HSP70. AS of HSP70 had no effect on any of these parameters in the AS group without preconditioning.
Effects of UP on recovery of E[Ca2+]i after caffeine administration in single ventricular myocyte subjected to MeI/A upon blockade of HSP70. To further investigate the uptake of Ca2+ by SERCA, the gradual recovery of E[Ca2+]i after caffeine administration was also measured (10, 24). As shown in the typical traces in Fig. 3A, the amplitude of E[Ca2+]i was decreased significantly immediately after the caffeine (10 µM) application, after which it gradually recovered. Recovery in UP was quicker than that in VP after both MeI/A and reperfusion. Group results showed that at the 50th second (Fig. 3B), the amplitude of E[Ca2+]i in UP was 80% of its control, whereas the corresponding value in VP was 64% after 10 min of MeI/A. After 10-min reperfusion, the values were 84% and 68% in the UP and VP groups, respectively. The differences were significant (P < 0.01 and P < 0.05, respectively). AS of HSP70 reversed the effect of UP to the level of the VP group.
|
|
Effects of UP on expression of RyR, SERCA, and NCX in ventricular myocytes subjected to MeI/A upon blockade of HSP70. The expression of both RyR (Fig. 5A) and SERCA (Fig. 5B) in UP was enhanced significantly compared with that in the VP group after MeI/A and reperfusion. Moreover, after blocking HSP70 synthesis with AS, the expression of both proteins was returned to the same level as that in the VP group (Fig. 5, A and B). In contrast, there was no difference in NCX expression between groups (Fig. 5C), indicating that this was not affected by UP.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
-OR stimulation, which confers delayed cardioprotection, also attenuates the [Ca2+]i overload (6), which is believed to precipitate cardiac injury (23). Blockade of the synthesis of HSP70 abolishes the attenuating effects on cardiac injury and [Ca2+]i overload, indicating an important role of HSP70 in cardioprotection and Ca2+ homeostasis (13). We hypothesized that activation of HSP70 restored Ca2+ homeostasis by restoring the actions at multiple sites involved in Ca2+ handling. We therefore further delineated the relationship between HSP70 and Ca2+ handling, with particular attention to RyR and SERCA in SR and NCX in sarcolemma. We determined the C[Ca2+]i and E[Ca2+]i, which provide information about overall dynamic changes in Ca2+ handling; expression of Ca2+ regulatory proteins, RyR, SERCA, and NCX; and Ca2+ fluxes across NCX. We found that preconditioning with a
-OR agonist, U50488H, which was shown previously to confer delayed cardioprotection and attenuate [Ca2+]i overload in the rat ventricular myocyte (13), increased the expression and activities of RyR and SERCA as well as the activity of NCX in the ventricular myocyte. All of these changes were abolished or attenuated after blockade of the synthesis of HSP70 with a selective AS, indicating that these changes, which restore the Ca2+ homeostasis impaired by simulated ischemia, are due in part to activation of HSP70. The results not only confirm our previous finding that activation of HSP70 attenuates the [Ca2+]i overload induced by simulated ischemia but also, more importantly, provide information regarding the effects of HSP70 on Ca2+ handling at multiple sites, namely, RyR, SERCA, and NCX, which is responsible in part for the attenuation of Ca2+ overload, improved recovery in contractile functions, and cardioprotection. Like [Ca2+]i, the [Ca2+]m in the ventricular myocyte was reduced after UP and the effect was also abolished by blockade of HSP70 synthesis. The similar responses in [Ca2+]i and [Ca2+]m are expected as Ca2+ from SR is released to the cytoplasm via RyR as well as transferred to mitochondria via local coupling between closely apposed regions of the SR and mitochondria (9). Because attenuation in overload of [Ca2+]m, but not [Ca2+]i, was shown to be responsible for postischemic recovery in contractile function (14), the cardioprotective effect of UP against simulated ischemia is most likely due to attenuated [Ca2+]m overload, and the loss of protection after blockade of HSP70 synthesis is due to failure to attenuate [Ca2+]m overload.
In the present study, we found that the amplitude and the time to peak of the E[Ca2+]i were increased in the UP group, which was accompanied by an increased expression of RyR. Furthermore, the amplitude of the C[Ca2+]i was also increased, reflecting an increased Ca2+ content in the SR. These observations indicate that the release of Ca2+ from the SR was faster and greater, which is most likely due to increased activity of RyR and increased availability of Ca2+ from the SR.
We also found in the present study that the decay of the E[Ca2+]i was shorter after preconditioning with a
-OR agonist and that the recovery in amplitude of E[Ca2+]i after depletion of Ca2+ from the SR by caffeine was faster. These observations indicate a faster uptake of Ca2+ by the SR after preconditioning. This is most likely due to increased SERCA activity as reflected by the increased expression of the protein.
The NCX activity was also increased after preconditioning as indicated by a shorter decay time of the C[Ca2+]i and a greater NCX activity determined in the 45Ca2+ flux study. Interestingly, the increased activity was not accompanied by an increased expression of NCX, suggesting that the increased activity is not secondary to increased expression of the protein.
The present study has shown that preconditioning with
-OR stimulation increased the release of Ca2+ from SR via the RyR. It also sped up the rate of removal of Ca2+ from cytoplasm by increasing uptake via SERCA and removal via NCX. In a previous study (10), we also observed similar changes in Ca2+ handling in the rat ventricular myocyte immediately after the addition of UP, which confers early cardioprotection. The increased release of Ca2+ from the SR, as reflected by an increased amplitude of E[Ca2+]i, is responsible for improved recovery in contractile function. The efficient removal of Ca2+ from cytoplasm prevents [Ca2+]i overload, thus protecting the heart.
In normal conditions, HSP70 family members function as molecular chaperones by assisting in folding and assembly of newly synthesized proteins and by transporting these proteins to various organelles. Upon stress such as heat stress, which induces cell death, the inducible form HSP70 is activated and protects cells from apoptosis (16, 17). There is now evidence that CHOP-induced apoptosis is mediated by translocation of Bax, a proapoptotic member of the Bcl family, from the cytosol to the mitochondria (7). Pairing with its cochaperone, DnaJ, which is known to regulate its function (12), HSP70 interacts with Bax and prevents its translocation to mitochondria, thus inhibiting apoptosis (7). It has also been shown that in HeLa cells, induction of Bax increases endoplasmic reticulum Ca2+ loading and [Ca2+]m level (3), an upstream signal for cytochrome c release in some forms of apoptosis (19, 20). In our previous (13) and present studies, we found that [Ca2+]i overload during simulated ischemia and reperfusion was significantly attenuated by UP, which increased HSP70 expression. In the present study, we also found that the [Ca2+]m overload during reperfusion was significantly attenuated by UP. Blockade of synthesis of the protein with selective AS abolished the effects of UP, indicating that HSP70 is responsible for the cytosolic and mitochondrial responses. Therefore, interaction of HSP70 with Bax may be responsible for the actions of UP on Ca2+ homeostasis. In the present study, we showed that UP reversed the effects of simulated ischemia on expression and activity of RyR and SERCA, suggesting that Bax may affect the RyR and SERCA. In the present study, we also observed that UP affected the NCX activity. There is no evidence, however, suggesting a potential link with Bax. Further study is needed to confirm that Bax affects cytosolic and mitochondrial Ca2+ by affecting RyR and SERCA and to delineate the relationship between Bax and NCX.
Mitochondrial HSP70, a member of HSP70 family located in mitochondria, is a constitutive HSP with a 75-kDa molecular mass, whereas HSP70 is an inducible HSP of 70 kDa, and peptide mapping indicates that they are unique polypeptides (15). Basic Local Alignment Search Tool analysis does not show that the AS oligonucleotides used in our study match this protein. Therefore, it is unlikely that the AS oligonucleotides used in our study target mitochondrial HSP70. On the other hand, the mitochondrial HSP70 has been shown to play an important role in translocating cytosolic precursor proteins across the two mitochondrial membranes (26). It has been shown that HSP70 interacts with Bax and prevents its translocation to mitochondria. Whether mitochondrial HSP70 is involved in this process warrants further study.
Vitadello and co-workers (25) found that selective increase in glucose-regulated protein (GRP94), a member of the HSP90 family, protects cardiomyocytes against injury induced by ischemia or [Ca2+]i overload counteracting [Ca2+]i elevations. The finding indicates that in addition to HSP70, other heat shock proteins are also involved in Ca2+ homeostasis. More interesting and more important is that in human neuroblastoma cells, A-23187 (a Ca2+ ionophore) induces cell injury and increases the expression of GRP94, and overexpression of the protein suppresses A-23187-induced injury and stabilizes Ca2+ homeostasis (1). This study suggests a causal relationship between attenuation of [Ca2+]i overload and cardiac protection upon increased expression/activation of heat shock proteins.
In conclusion, the present study has shown that activation of HSP70, which confers delayed cardioprotection, increased the release of Ca2+ via RyR and sped up the uptake of Ca2+ via SERCA and removal of Ca2+ via NCX in the rat cardiomyocytes. These actions restored Ca2+ homeostasis and attenuated [Ca2+]i overload. The study has also provided evidence for the first time that activation of HSP70 attenuated [Ca2+]m overload.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87: 275281, 2000.
3. Chami M, Prandini A, Campanella M, Pinton P, Szabadkai G, Reed JC, and Rizzuto R. Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region. J Biol Chem 279: 5458154589, 2004.
4. Chan JY, Ou CC, Wang LL, and Chan SH. Heat shock protein 70 confers cardiovascular protection during endotoxemia via inhibition of nuclear factor-
B activation and inducible nitric oxide synthase expression in the rostral ventrolateral medulla. Circulation 110: 35603566, 2004.
5. Chan SH, Chang KF, Ou CC, and Chan JY. Up-regulation of glutamate receptors in nucleus tractus solitarii underlies potentiation of baroreceptor reflex by heat shock protein 70. Mol Pharmacol 61: 10971104, 2002.
6. Chen M, Zhou JJ, Kam KW, Qi JS, Yan WY, Wu S, and Wong TM. Roles of KATP channels in delayed cardioprotection and intracellular Ca2+ in the rat heart as revealed by
-opioid receptor stimulation with U50488H. Br J Pharmacol 140: 750758, 2003.[CrossRef][ISI][Medline]
7. Gotoh T, Terada K, Oyadomari S, and Mori M. hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 11: 390402, 2004.[CrossRef][ISI][Medline]
8. Guatimosim S, Dilly K, Santana LF, Saleet Jafri M, Sobie EA, and Lederer WJ. Local Ca2+ signaling and EC coupling in heart: Ca2+ sparks and the regulation of the [Ca2+]i transient. J Mol Cell Cardiol 34: 941950, 2002.[CrossRef][ISI][Medline]
9. Hajnoczky G, Csordas G, and Yi M. Old players in a new role: mitochondria-associated membranes, VDAC, and ryanodine receptors as contributors to calcium signal propagation from endoplasmic reticulum to the mitochondria. Cell Calcium 32: 363377, 2002.[CrossRef][ISI][Medline]
10. Ho JC, Wu S, Kam KW, Sham JS, and Wong TM. Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia. Br J Pharmacol 137: 739748, 2002.[CrossRef][ISI][Medline]
11. Kim YM, de Vera ME, Watkins SC, and Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272: 14021411, 1997.
12. Laufen T, Mayer MP, Beisel C, Klostermeier D, Mogk A, Reinstein J, and Bukau B. Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc Natl Acad Sci USA 96: 54525457, 1999.
13. Liu J, Kam KW, Zhou JJ, Yan WY, Chen M, Wu S, and Wong TM. Effects of heat shock protein 70 activation by metabolic inhibition preconditioning or
-opioid receptor stimulation on Ca2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther 310: 606613, 2004.
14. Miyamae M, Camacho SA, Weiner MW, and Figueredo VM. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. Am J Physiol Heart Circ Physiol 271: H2145H2153, 1996.
15. Mizzen LA, Chang C, Garrels JI, and Welch WJ. Identification, characterization, and purification of two mammalian stress proteins present in mitochondria, grp 75, a member of the hsp 70 family and hsp 58, a homolog of the bacterial groEL protein. J Biol Chem 264: 2066420675, 1989.
16. Mosser DD, Caron AW, Bourget L, Denis-Larose C, and Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17: 53175327, 1997.[Abstract]
17. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, and Massie B. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20: 71467159, 2000.
18. Murata M, Akao M, ORourke B, and Marban E. Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 89: 891898, 2001.
19. Nutt LK, Chandra J, Pataer A, Fang B, Roth JA, Swisher SG, ONeil RG, and McConkey DJ. Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis. J Biol Chem 277: 2030120308, 2002.
20. Nutt LK, Pataer A, Pahler J, Fang B, Roth JA, McConkey DJ, and Swisher SG. Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem 277: 92199225, 2002.
21. Pei JM, Kravtsov GM, Wu S, Das R, Fung ML, and Wong TM. Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study. Am J Physiol Cell Physiol 285: C1420C1428, 2003.
22. Sham JS, Hatem SN, and Morad M. Species differences in the activity of the Na+-Ca2+ exchanger in mammalian cardiac myocytes. J Physiol 488: 623631, 1995.
23. Steenbergen C, Murphy E, Watts JA, and London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66: 135146, 1990.
24. Trafford AW, Diaz ME, and Eisner DA. Coordinated control of cell Ca2+ loading and triggered release from the sarcoplasmic reticulum underlies the rapid inotropic response to increased L-type Ca2+ current. Circ Res 88: 195201, 2001.
25. Vitadello M, Penzo D, Petronilli V, Michieli G, Gomirato S, Menabo R, Di Lisa F, and Gorza L. Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J 17: 923925, 2003.
26. Voos W and Röttgers K. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta 1592: 5162, 2002.[Medline]
27. Wu S, Li HY, and Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of
-opioid receptor. Circ Res 84: 13881395, 1999.
28. Yu XC, Li HY, Wang HX, and Wong TM. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes: cross-talk between
-opioid and
-adrenergic receptors. J Mol Cell Cardiol 30: 405413, 1998.[CrossRef][ISI][Medline]
29. Zhou JJ, Pei JM, Wang GY, Wu S, Wang WP, Cho CH, and Wong TM. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 281: H40H47, 2001.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |